News at a glance: AI rules for Europe, vaccines for Africa, and a union for NIH early-career researchers
HEALTH EQUITY
A billion-dollar boost for vaccinemaking in Africa
Gavi, the Vaccine Alliance, has committed up to $1 billion to bolster Africa’s ability to sustainably produce its own doses of lifesaving vaccines. Manufacturers based in Africa produce only 1% of the vaccine doses used on the continent. Last week, Gavi announced that with money left over from the COVID-19 Vaccines Global Access Facility—an effort to provide an equitable distribution of COVID-19 vaccines—it would create the African Vaccine Manufacturing Accelerator (AVMA) to focus on preventing 11 priority infectious diseases. As an incentive to begin making the doses, AVMA will give a manufacturer $10 million to $25 million for each vaccine that the World Health Organization determines meets international quality standards. If Gavi and its partner, UNICEF, agree to buy the vaccine, AVMA will “top up” the price paid by as much as 50 cents extra per dose as an “accelerator payment.” Its goal is to help at least four African manufacturers supply a total of more than 800 million doses over a decade.
REGULATION
EU agrees to landmark AI rules
After marathon negotiations, the European Union’s three main governing bodies last week approved a comprehensive new law governing the development and use of artificial intelligence (AI) systems across the bloc. The world’s first enacted legislation of its kind, the measure
bans certain application...
Source: ScienceNOW - Category: Science Source Type: news
More News: Academia | African Health | AIDS Vaccine | Australia Health | Biology | Cancer | Cancer & Oncology | Cancer Vaccines | Conferences | Covid Vaccine | COVID-19 | Databases & Libraries | Environmental Health | Fish | Food and Drug Administration (FDA) | France Health | Genetics | Government | Graduation | HIV AIDS | Infectious Diseases | International Medicine & Public Health | Internet | Molecular Biology | National Institutes of Health (NIH) | Pandemics | Politics | Prostate Cancer | Science | Sickle Cell Anemia | South Africa Health | Stem Cell Therapy | Stem Cells | Students | Study | Tanzania Health | Tax | Training | Uganda Health | UK Health | Universities | Universities & Medical Training | Vaccines | WHO | Women | Zimbabwe Health